- Home
- IMNN vs MCVT Comparison
IMNN vs MCVT Comparison
Compare IMNN & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- MCVT
- Stock Information
- Founded
- IMNN 1982
- MCVT 2007
- Country
- IMNN United States
- MCVT United States
- Employees
- IMNN N/A
- MCVT N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- MCVT Finance Companies
- Sector
- IMNN Health Care
- MCVT Finance
- Exchange
- IMNN Nasdaq
- MCVT Nasdaq
- Market Cap
- IMNN 12.2M
- MCVT 11.6M
- IPO Year
- IMNN 1985
- MCVT N/A
- Fundamental
- Price
- IMNN $0.83
- MCVT $1.99
- Analyst Decision
- IMNN Strong Buy
- MCVT
- Analyst Count
- IMNN 2
- MCVT 0
- Target Price
- IMNN $20.50
- MCVT N/A
- AVG Volume (30 Days)
- IMNN 395.1K
- MCVT 5.7K
- Earning Date
- IMNN 11-07-2024
- MCVT 11-12-2024
- Dividend Yield
- IMNN N/A
- MCVT N/A
- EPS Growth
- IMNN N/A
- MCVT N/A
- EPS
- IMNN N/A
- MCVT 0.05
- Revenue
- IMNN N/A
- MCVT $3,234,265.00
- Revenue This Year
- IMNN N/A
- MCVT N/A
- Revenue Next Year
- IMNN N/A
- MCVT N/A
- P/E Ratio
- IMNN N/A
- MCVT $40.51
- Revenue Growth
- IMNN N/A
- MCVT N/A
- 52 Week Low
- IMNN $0.48
- MCVT $1.75
- 52 Week High
- IMNN $3.65
- MCVT $3.88
- Technical
- Relative Strength Index (RSI)
- IMNN 47.27
- MCVT 51.73
- Support Level
- IMNN $0.80
- MCVT $1.91
- Resistance Level
- IMNN $0.88
- MCVT $2.05
- Average True Range (ATR)
- IMNN 0.05
- MCVT 0.06
- MACD
- IMNN 0.00
- MCVT 0.01
- Stochastic Oscillator
- IMNN 25.00
- MCVT 52.38
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.